Protagenic Therapeutics Stock Technical Analysis
| PTIXW Stock | USD 0.01 0 11.11% |
As of the 27th of November, Protagenic Therapeutics holds the Coefficient Of Variation of 2271.48, risk adjusted performance of 0.0434, and Semi Deviation of 18.39. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protagenic Therapeutics, as well as the relationship between them. Please check Protagenic Therapeutics variance and potential upside to decide if Protagenic Therapeutics is priced some-what accurately, providing market reflects its current price of 0.008 per share. As Protagenic Therapeutics appears to be a penny stock we also advise to check out its total risk alpha numbers.
Protagenic Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Protagenic, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProtagenicProtagenic |
Protagenic Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Protagenic Therapeutics Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Protagenic Therapeutics Trend Analysis
Use this graph to draw trend lines for Protagenic Therapeutics. You can use it to identify possible trend reversals for Protagenic Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Protagenic Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Protagenic Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Protagenic Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0003 , which may suggest that Protagenic Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Protagenic Therapeutics price change compared to its average price change.About Protagenic Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Protagenic Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Protagenic Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Protagenic Therapeutics price pattern first instead of the macroeconomic environment surrounding Protagenic Therapeutics. By analyzing Protagenic Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Protagenic Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Protagenic Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Payables Turnover | 0.25 | 0.24 | Days Of Inventory On Hand | 269.53 | 275.1 |
Protagenic Therapeutics November 27, 2024 Technical Indicators
Most technical analysis of Protagenic help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Protagenic from various momentum indicators to cycle indicators. When you analyze Protagenic charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0434 | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 17.68 | |||
| Semi Deviation | 18.39 | |||
| Downside Deviation | 25.8 | |||
| Coefficient Of Variation | 2271.48 | |||
| Standard Deviation | 28.83 | |||
| Variance | 831.04 | |||
| Information Ratio | 0.0396 | |||
| Jensen Alpha | 1.61 | |||
| Total Risk Alpha | (3.22) | |||
| Sortino Ratio | 0.0442 | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 159.98 | |||
| Value At Risk | (41.67) | |||
| Potential Upside | 60.49 | |||
| Downside Variance | 665.68 | |||
| Semi Variance | 338.11 | |||
| Expected Short fall | (37.68) | |||
| Skewness | 1.18 | |||
| Kurtosis | 2.83 |
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.